Guidelines on migraine: Part 3. Recommendations for individual drugs.
Morey
S S
SS
D000700:Analgesics / Q000627:therapeutic use*; D000932:Antiemetics / Q000627:therapeutic use*; D004878:Ergotamine / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D000700:Analgesics; D000932:Antiemetics; D006993:Hypnotics and Sedatives; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D004878:Ergotamine